Cancer News and Research

Latest Cancer News and Research

New study says surgery still the best option for prostate cancer

A study by Swedish researchers has found that men who opt to have cancerous prostates surgically removed, have higher long-term survival rates than those who delay the operation, and the benefits of surgery may be greatest for men under 65.

11 May 2005

Research reveals atomic structure of angiopoietin-2, a key protein involved in the neo-vascularization of solid tumors

A structural biologist from the Virginia Commonwealth University Massey Cancer Center, in collaboration with researchers at Memorial Sloan-Kettering Cancer Center, has identified the crystal structure of a protein that plays a role in supplying nutrients to solid tumors.

11 May 2005

Virus that targets and kills glioblastoma

Yale School of Medicine scientists have identified a virus that targets and kills glioblastoma, a deadly type of human brain tumor resistant to current medical or surgical treatment, according to a study published as the cover article in the Journal of Virology.

11 May 2005

Discovery may pave way for immunotherapies for prostate cancer

Using a common chemotherapy agent, researchers at UCLA's Jonsson Cancer Center and the Department of Pathology and Laboratory Medicine found a way to move an important biomarker expressed in prostate cancer, shaking it loose from one location in a cell – where it could not be accessed by blood – to another, easier to target area.

11 May 2005

Broken bones may reduce risk of ovarian cancer

The pain and suffering of a broken bone may yield an unexpected benefit – a reduced risk of ovarian cancer.

10 May 2005

Breast CT may improve on mammography - more gentler, more accurate

A new breast screening technology that may be able to detect tumors earlier than mammography -- without the need for uncomfortable breast compression -- is being tested in patients at the University of California, Davis, Medical Center.

10 May 2005

New laser technology for more precise cancer treatments

Tom Cowan’s team is thinking smaller, but with big impact. Particle accelerators are a key research tool in a high energy physicist’s arsenal, but they take up a lot of space - miles and miles of it. But at the University of Nevada, Reno, smaller is better.

10 May 2005

Major Northern Ireland survey to seek public views on cancer

A major postal survey which will help raise cancer awareness is being conducted by the University of Ulster and funded by the Ulster Cancer Foundation.

10 May 2005

No glass ceiling for women when it comes to dying from heart disease, say experts

While many of us assume that heart disease mainly strikes men, the fact is 12,000 Australian women die each year from illnesses like stroke, heart attack and heart failure - that's four and a half times the number of lives claimed by breast cancer.

10 May 2005

Research offers new molecular approaches to therapies for the most deadly cancers

Researchers at Wake Forest University Baptist Medical Center have found promising new molecular targets and treatment approaches for some of the most malignant brain tumors.

10 May 2005

Cytogen Corporation and Dowpharma collaborate to create a targeted oncology product designed to treat prostate and other cancers

Under the agreement, Dowpharma's proprietary MeO-DOTA bifunctional chelant technology will be used to radiolabel Cytogen's prostate-specific membrane antigen (PSMA) antibody with a therapeutic radionuclide. PSMA is a protein highly expressed on the surface of prostate cancer cells and the neovasculature of many solid tumors.

10 May 2005

Laboratory model of immune system overcomes ethical constraints on studies of hematopoietic stem cells in humans

Scientists at St. Jude Children’s Research Hospital have joined with colleagues at several other institutions to develop a laboratory model of the human immune system. This model will allow scientists to study ways for improving the results of hematopoietic stem cell (HSC) transplantation without putting patients at risk.

10 May 2005

A new approach to prevent cancer

Researchers at the University of Dundee have identified a way of inactivating a naturally occurring human protein, a development which could offer new routes to developing cancer prevention treatments.

10 May 2005

Obesity appears to worsen and possibly cause asthma

Obesity is a known risk factor for type II diabetes, heart disease and some forms of cancer. Evidence is now mounting that obesity is also a risk factor for asthma.

10 May 2005

Americans willing to pay more for greater vaccine coverage

How much is it worth to you and your family to have a health insurance plan that covers the latest innovations in adult and childhood vaccines for certain types of cancer or even influenza and pneumonia?

10 May 2005

Poor understanding of insurance benefits deters many women from breast screening

According to a new study, one of the most commonly reported barriers to breast cancer screening in the U.S., financial burden, may often be the result of misperception.

10 May 2005

BMA calls for mass child vaccinations for hepatitis B virus (HBV)

The British Medical Association (BMA) has today called for all children in the UK to be immunised against a potentially fatal liver disease caused by the hepatitis B virus (HBV).

9 May 2005

A combination of chemotherapy drugs could double survival rates for pancreatic cancer

Pancreatic cancer has a poor prognosis. More than 80% of patients present with advanced disease at diagnosis, and mortality is high. A single chemotherapy drug, gemcitabine, is regarded as the standard treatment, but it has lead to a 1-year overall survival of only 17—28% in clinical trials.

9 May 2005

Carbonated soft drinks can cause heartburn

Carbonated soft drinks and one of the most commonly prescribed sleeping pills, benzodiazepines, can cause nighttime heartburn, according to new research.

9 May 2005

Scientists inhibit tumor formation

By studying mice with skin cancer, researchers at the Huntsman Cancer Institute at the University of Utah discovered a way to inhibit a mutant gene found in up to 30 percent of human tumors.

9 May 2005

Cancer News and Research

Latest Cancer News and Research

New study says surgery still the best option for prostate cancer

Research reveals atomic structure of angiopoietin-2, a key protein involved in the neo-vascularization of solid tumors

Virus that targets and kills glioblastoma

Discovery may pave way for immunotherapies for prostate cancer

Broken bones may reduce risk of ovarian cancer

Breast CT may improve on mammography - more gentler, more accurate

New laser technology for more precise cancer treatments

Major Northern Ireland survey to seek public views on cancer

No glass ceiling for women when it comes to dying from heart disease, say experts

Research offers new molecular approaches to therapies for the most deadly cancers

Cytogen Corporation and Dowpharma collaborate to create a targeted oncology product designed to treat prostate and other cancers

Laboratory model of immune system overcomes ethical constraints on studies of hematopoietic stem cells in humans

A new approach to prevent cancer

Obesity appears to worsen and possibly cause asthma

Americans willing to pay more for greater vaccine coverage

Poor understanding of insurance benefits deters many women from breast screening

BMA calls for mass child vaccinations for hepatitis B virus (HBV)

A combination of chemotherapy drugs could double survival rates for pancreatic cancer

Carbonated soft drinks can cause heartburn

Scientists inhibit tumor formation

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in